About usHistoryCulture
EHS SystemQuality System
APICDMO
Work PhilosophyRecruitment News
To be the Reliable Supplier in the Global Pharmaceutical Supply Chain
Home > Business > API
API CDMO
Cas No.：868540-17-4
Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC50 of 5 nM in ANBL-6 and RPMI 8226 cells.
E-mail Product Inquiry
Title：
Cas No.：
Name：
Telephone：
E-mail：
Message：
Submit
